BNP Paribas Upgrades Novonesis to Neutral Rating

By EC Assets · Published 3 July 2026

BNP Paribas has upgraded Novonesis. The firm changed its recommendation to Neutral from Underperform. The price target for Novonesis has been set at 415 Danish kroner (DKK). BNP Paribas Exane analyst Nicola Tang issued the upgrade. The upgrade applies to Novonesis A/S (NSISB:DC). Novonesis received a double lift, including both its recommendation and its price target. BNP Paribas analysts still maintain a skeptical view of the company. Other financial news outlets also reported this upgrade. These include marketscreener.com, zonebourse.com, placera.se, swedbank-aktiellt.se, and affarsvarlden.se. Novonesis’s B shares (NOVONESIS BR/RG-B) had a reference value of 421.950 DKK. This represented a 0.33% decline. The indicative value was 56.448 EUR. This article is intended for informational purposes only. It does not constitute investment advice.